BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25326395)

  • 1. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
    Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
    Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer.
    Morikawa T; Kuchiba A; Qian ZR; Mino-Kenudson M; Hornick JL; Yamauchi M; Imamura Y; Liao X; Nishihara R; Meyerhardt JA; Fuchs CS; Ogino S
    Ann Surg Oncol; 2012 Jun; 19(6):1944-53. PubMed ID: 22189472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
    Ogino S; Brahmandam M; Cantor M; Namgyal C; Kawasaki T; Kirkner G; Meyerhardt JA; Loda M; Fuchs CS
    Mod Pathol; 2006 Jan; 19(1):59-68. PubMed ID: 16118624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
    Lochhead P; Imamura Y; Morikawa T; Kuchiba A; Yamauchi M; Liao X; Qian ZR; Nishihara R; Wu K; Meyerhardt JA; Fuchs CS; Ogino S
    Eur J Cancer; 2012 Dec; 48(18):3405-13. PubMed ID: 22840368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
    Benedix F; Kuester D; Meyer F; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma.
    Sung CO; Seo JW; Kim KM; Do IG; Kim SW; Park CK
    Mod Pathol; 2008 Dec; 21(12):1533-41. PubMed ID: 18849918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
    Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
    Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival.
    Kermanshahi TR; Magge D; Choudry H; Ramalingam L; Zhu B; Pingpank J; Ahrendt S; Holtzman M; Zeh H; Bartlett D; Zureikat A; Pai RK
    Int J Surg Pathol; 2017 Apr; 25(2):108-117. PubMed ID: 27571790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
    Nosho K; Shima K; Irahara N; Kure S; Firestein R; Baba Y; Toyoda S; Chen L; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
    Mod Pathol; 2009 Jul; 22(7):922-32. PubMed ID: 19430421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
    Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
    Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
    Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
    Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
    Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
    PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
    Hartman DJ; Binion DG; Regueiro MD; Miller C; Herbst C; Pai RK
    Inflamm Bowel Dis; 2018 Jul; 24(8):1780-1790. PubMed ID: 29788391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Histopathologic Features of Colorectal Adenocarcinoma in Crohn's Disease.
    Galata C; Hirsch D; Reindl W; Post S; Kienle P; Boutros M; Gaiser T; Horisberger K
    J Clin Gastroenterol; 2018 Aug; 52(7):635-640. PubMed ID: 28654553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between molecular subtypes of colorectal cancer and patient survival.
    Phipps AI; Limburg PJ; Baron JA; Burnett-Hartman AN; Weisenberger DJ; Laird PW; Sinicrope FA; Rosty C; Buchanan DD; Potter JD; Newcomb PA
    Gastroenterology; 2015 Jan; 148(1):77-87.e2. PubMed ID: 25280443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.